Ginsenosides: Allies of gastrointestinal tumor immunotherapy

In the past decade, immunotherapy has been the most promising treatment for gastrointestinal tumors. But the low response rate and drug resistance remain major concerns. It is therefore imperative to develop adjuvant therapies to increase the effectiveness of immunotherapy and prevent drug resistanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Yutao, Ma, Fen, Wu, Enjiang, Cheng, Zewei, Wang, Zhengtao, Yang, Li, Zhang, Jiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659574/
https://www.ncbi.nlm.nih.gov/pubmed/36386161
http://dx.doi.org/10.3389/fphar.2022.922029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659574/
https://www.ncbi.nlm.nih.gov/pubmed/36386161
http://dx.doi.org/10.3389/fphar.2022.922029

Ejemplares similares